Secures $2.2M in Series A Funding, a San Francisco-based virtual nurse platform, secured $2.2m in Series A funding.

Backers included Launchpad Digital Health, Fenox Venture Capital and TA Ventures.

The company intends to use the funds to launch new markets, expand its support of its global customer base, and drive enhancements to its product, particularly in artificial intelligence and machine learning.

Led by Co-Founder and CEO Adam Odessky, provides a virtual nurse platform for patient engagement and chronic disease monitoring. Its mobile-first virtual nurse, Molly, engages patients with natural conversation through a wide variety of circumstances from simple administrative needs through complex chronic conditions requiring medical assistance. Patients can take their vitals measurements; chat about their pain, sleep, stress, and diet; or be connected to an attending physician via video call, if patients show elevated risks.
Customers and partners include the National Health Service of the UK, Dudley CCG, Novartis, and UCSF.



Join the discussion